Cite
Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system
MLA
Daisuke Hanashi, et al. “Zymosan Enhances the Immune Response to DNA Vaccine for Human Immunodeficiency Virus Type-1 through the Activation of Complement System.” Immunology, vol. 103, no. 1, June 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....871cdaac2424d51de64476c873d57bb3&authtype=sso&custid=ns315887.
APA
Daisuke Hanashi, Yuki Ara, Kenji Okuda, Eri Hagiwara, Yohei Miyagi, Mitsugu Sugiyama, Norihisa Ishii, Takuji Yoshida, Tomoyuki Saito, Hidechika Okada, Toshitaka Takagi, Tumihisa Koshino, & Susumu Kawamoto. (2001). Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology, 103(1).
Chicago
Daisuke Hanashi, Yuki Ara, Kenji Okuda, Eri Hagiwara, Yohei Miyagi, Mitsugu Sugiyama, Norihisa Ishii, et al. 2001. “Zymosan Enhances the Immune Response to DNA Vaccine for Human Immunodeficiency Virus Type-1 through the Activation of Complement System.” Immunology 103 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....871cdaac2424d51de64476c873d57bb3&authtype=sso&custid=ns315887.